Company

Smart Assays has been a key factor in the regulatory submissions and financing rounds of public and private life science companies providing hands-on expertise and tailor-made R&D services for evaluation and validation of early and clinical-stage projects.

Smart Assays reflects a unique work model – a combination of proficiency in analytical chemistry and biochemical processes, provided by a skilled, creative team with extensive and cumulative scientific knowledge and a proven track record in assay development, drug discovery, MOA and POC studies, research histopathology and bioanalytic research.

​

Established in 2005, Smart Assays operates in a 350m² state-of-the-art facility situated in the Weizmann Science Park in the heart of Israel’s entrepreneurial Life Science and Biotech ecosystem.